Kenneth T. Mills, Director at REGENXBIO Inc. (RGNX), sold 41,204 shares at $7.91 ($326K) on 2025-05-12, disclosed to the SEC on 2025-05-14.
Scheduled sale ($326k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.91 | 20,602 | $163K | 50.0% |
| 2 | $7.91 | 20,602 | $163K | 50.0% |
| Total | $7.91 avg | 41,204 | $326K | 100% |
| Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |
| RGNX | SELL | 2024-03-18 | $328K | — | Filing → |